Skip to main content
OpenTrials

Clinical trial condition

Hyperparathyroidism, Secondary

Explore clinical trials studying Hyperparathyroidism, Secondary. Study availability and eligibility vary by location and protocol.

148 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Hyperparathyroidism, Secondary trial results

Completed

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

NCT01149291

Conditions
Chronic Disease, Disease Attributes, End Stage Renal Disease, +16 more
Locations
  • Site Reference ID/Investigator# 37822 Antalya, Turkey (Türkiye)
  • Site Reference ID/Investigator# 68286 Antalya, Turkey (Türkiye)
  • Site Reference ID/Investigator# 40677 Antalya, Turkey (Türkiye)
  • Site Reference ID/Investigator# 85153 Istanbul, Turkey (Türkiye)
View all 22 locations
View Trial Details
Completed

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

NCT01083849

Conditions
Chronic Disease, Disease Attributes, Endocrine System Diseases, +18 more
Locations
  • Site Reference ID/Investigator# 64522 Feldkirch, Austria
  • Site Reference ID/Investigator# 53506 Graz, Austria
  • Site Reference ID/Investigator# 53524 Graz, Austria
  • Site Reference ID/Investigator# 74733 Innsbruck, Austria
View all 87 locations
View Trial Details
Completed

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

NCT00742716

Conditions
Chronic Disease, Chronic Kidney Disease, Chronic Renal Failure, +18 more
Locations
  • Pines Clinical Research, Inc. Pembroke Pines, Florida, United States
  • Boise Kidney and Hypertension Institute Meridian, Idaho, United States
  • Western New England Renal & Transplant Associates (WNERTA) Springfield, Massachusetts, United States
  • Southeast Renal Research Institute Chattanooga, Tennessee, United States
View Trial Details
Completed

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

NCT00888069

Conditions
Chronic Disease, Chronic Kidney Disease, Chronic Renal Failure, +18 more
Locations
  • Pivotal Research Centers Peoria, Arizona, United States
  • Research by Design Evergreen Park, Illinois, United States
  • Western New England Renal & Transplant Associates Springfield, Massachusetts, United States
  • Twin Cities Clinical Research Brooklyn Center, Minnesota, United States
View Trial Details
Completed

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

NCT00792857

Conditions
Chronic Disease, Chronic Kidney Disease, Chronic Renal Failure, +18 more
Locations
  • Pivotal Reseach Centers Peoria, Arizona, United States
  • Western New England Renal and Transplant Associates Springfield, Massachusetts, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Northeast Clinical Research Allentown, Pennsylvania, United States
View Trial Details
Completed

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

NCT01224782

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations
  • Site Reference ID/Investigator# 66544 Montana, Bulgaria
  • Site Reference ID/Investigator# 47685 Pleven, Bulgaria
  • Site Reference ID/Investigator# 66546 Plovdiv, Bulgaria
  • Site Reference ID/Investigator# 47683 Sofia, Bulgaria
View all 69 locations
View Trial Details
Completed

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

NCT00823303

Conditions
Calcium Metabolism Disorders, Chronic Disease, Chronic Kidney Disease, +20 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Northshore University Health System Evanston, Illinois, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Washington University St Louis, Missouri, United States
View Trial Details

Related conditions